 Subjects with a 5 cm2, non-infected target ulcer that has not reduced in area by 40 since the Screening visit will be randomized at Day 0 to either Apligraf or Control. After enrollment of 25 subjects, randomization will be discontinued and all remaining subjects will receive Apligraf. 